Drugs Made In America Acquisition DMAAU
NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAU) Interest & Investment Income (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Interest & Investment Income came in at $2.3 million in Q4 2025, down 5.96% on a QoQ basis from $2.4 million in Q3 2025.

Drugs Made In America Acquisition Corp. (DMAAU) Interest & Investment Income (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of Interest & Investment Income data on file, last reported at $2.3 million in Q4 2025.

  • Quarterly Interest & Investment Income changed N/A year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.8 million (changed N/A YoY) and the FY2025 annual result came in at $8.8 million, changed N/A from the prior year.
  • Interest & Investment Income slipped to $2.3 million in Q4 2025, from $2.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.4 million in Q3 2025 to a low of $1.6 million in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 2.30 Mn
Sep 30, 2025 2.45 Mn
Jun 30, 2025 2.42 Mn
Mar 31, 2025 1.59 Mn